Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | DCTPP1 | Q9H773 | 4/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.44 |
| ▸ | NPBWR1 | P48145 | 4/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | CASP7 | P55210 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11943539 | 0.89 | SMN1; SMN2 (0.58) | SMN1; SMN2LMNAPOLBKMT2AGAA | |
| SCHEMBL17058573 | 0.88 | GAA (0.48) | SMN1; SMN2LMNAPOLBKMT2AGAA | |
| SCHEMBL14080981 | 0.87 | SMN1; SMN2 (0.56) | SMN1; SMN2LMNAPOLBKMT2AGAA | |
| SCHEMBL17058086 | 0.85 | SMN1; SMN2 (0.56) | SMN1; SMN2LMNAPOLBKMT2AGAA | |
| SCHEMBL17057882 | 0.85 | SMN1; SMN2 (0.47) | SMN1; SMN2LMNAPOLBKMT2AGAA | |
| SCHEMBL11943326 | 0.84 | ALDH1A1 (0.49) | SMN1; SMN2LMNAPOLBKMT2AGAA | |
| SCHEMBL17058230 | 0.83 | SMN1; SMN2 (0.58) | SMN1; SMN2LMNAPOLBKMT2AGAA | |
| SCHEMBL17057923 | 0.81 | SMN1; SMN2 (0.44) | SMN1; SMN2LMNAPOLBKMT2AGAA | |
| SCHEMBL11943375 | 0.80 | MAPT (0.41) | SMN1; SMN2LMNAPOLBKMT2AGAA | |
| SCHEMBL11945593 | 0.80 | MAPT (0.56) | SMN1; SMN2LMNAPOLBKMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100158992-A1 | PIPERAZINE-SUBSTITUTED PYRIDAZINONE DERIVATIVES USEFUL AS GLUCAN SYNTHASE INHIBITORS | SCHERING CORPORATION (US) | 2010-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100158992-A1 | PIPERAZINE-SUBSTITUTED PYRIDAZINONE DERIVATIVES USEFUL AS GLUCAN SYNTHASE INHIBITORS | DPM1, GMPS, MAN2A1 | SMN1; SMN2 3332/4885LMNA 1760/4885POLB 1016/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.